Document is current
Any future updates will be listed below
-
Authors
Glover, Hannah https://orcid.org/0000-0001-6558-8878
Saßmannshausen, Torben
Bertrand, Quentin https://orcid.org/0000-0003-3476-1775
Trabuco, Matilde https://orcid.org/0000-0001-9234-8685
Slavov, Chavdar https://orcid.org/0000-0001-9441-0243
Bacchin, Arianna
Andres, Fabio
Kondo, Yasushi https://orcid.org/0000-0003-2131-575X
Stipp, Robin
Wranik, Maximilian
Khusainov, Georgii
Carrillo, Melissa https://orcid.org/0000-0002-0744-4486
Kekilli, Demet
Nan, Jie
Gonzalez, Ana https://orcid.org/0000-0001-8858-399X
Cheng, Robert https://orcid.org/0000-0001-7564-1230
Neidhart, Werner
Weinert, Tobias https://orcid.org/0000-0002-0339-3722
Leonarski, Filip
Dworkowski, Florian https://orcid.org/0000-0001-5004-8684
Kepa, Michal https://orcid.org/0000-0002-4045-3990
Wachtveitl, Josef https://orcid.org/0000-0002-8496-8240
Hennig, Michael https://orcid.org/0000-0002-1839-2351
Standfuss, Joerg https://orcid.org/0000-0001-8825-386X
- License Information
-
More Information
Article History
Received: 20 March 2024
Accepted: 27 November 2024
First Online: 30 December 2024
Competing interests
: Authors M.T., A.B., F.A., R.C., W.N., and M.H. are employees of LeadXpro Biotech A.G., a company offering services for GPCR drug design and developing own lead compounds. The other authors declare no competing interests.
